[from the 4/18/2016 issue of Smart Tech Investor]

To make room for the new recommendations we will be adding to the Breakthrough Tech Stocks portfolio we are revising the STI portfolios, as follows:

Investments Portfolio

The Investments portfolio will be merged with the Smart Tech 50 portfolio since it always includes the top 10 rated stocks according to our STR (Smart Tech Rating) system as indicated in the far right column. Clicking once the ‘STR’ column header will rank all 50 stocks from lowest (worst) to highest (best); clicking on it a second time will rank them from highest to lowest.

Next Wave Portfolio

We are keeping all of the Next Wave portfolio stocks currently trading above their stop loss levels, but selling those that have recently fallen below those important support levels including:

Marketo (MKTO)

New Relic (NEWR)

Qualys (QLYS)

Splunk (SPLK)

Tableau Software (DATA)

Medical Profits Portfolio

As described in Dr. Duarte’s “Sector Spotlight” article, we are closing out positions in the following stocks:

Greatbatch (GB)

Invacare (IVC)

Medivation (MDVN)

Neurocrine Biosciences (NBIX)

OmniComm Systems (OMCM)

Otonomy (OTIC)

Sanofi (SNY)

Sirona Dental Systems (SIRO)

Vertex Pharmaceuticals (VRTX)